Poland Breast Cancer Therapeutics Market Analysis

Poland Breast Cancer Therapeutics Market Analysis


$ 3999

Poland's breast cancer therapeutics market size is expected to witness growth from $106 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-30. The major market drivers for Poland's breast cancer therapeutics market are increased are rapid advancements in treatment options and the increasing incidence of breast cancer in Poland. The market is segmented by therapy, by cancer type, and by distribution channel. Some leading companies in Poland's breast cancer therapeutics market are Polpharma, Bristol-Myers Squibb, and Eli Lilly.

ID: IN10PLPH031 CATEGORY: Pharmaceuticals GEOGRAPHY: Poland AUTHOR: Parul Choudhary

Buy Now

Poland Breast Cancer Therapeutics Market Executive Analysis

Poland's breast cancer therapeutics market size is at around $106 Mn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. Budget receipts are projected at $111.31 Bn and expenditures at $118.48 Bn in 2022. This results in a $7.14 Bn budget deficit for the national government. This year, the general government deficit is expected to drop from 5.3% of GDP to 2.8%. The Polish Parliament passed a bill requiring the state budget to set aside funds for health care funding in the amount of no less than 7% of GDP annually, with no less than 5.30% of GDP in 2021 and 5.75% in 2022.

Every year in Poland, more than 5,000 women die from breast cancer and over 15,000 new cases are identified. The American National Cancer Institute estimates that a woman's lifetime risk of developing breast cancer is 12% and rises with age. Most cases are observed in women between the ages of 50 and 69. The clinical stage of the tumour determines the likelihood of a successful course of treatment for breast cancer. Early diagnosis is therefore essential for survival and improves treatment outcomes. The ability and resources of the health system, awareness, and access to screening and care are a few aspects that are important for early diagnosis. The Polish parliament passed the National Strategy for Oncology 2020–2030 plan. The strategy focuses national efforts on achieving UN objectives through enhancing population screening programmes, evidence-based prevention, efficient cancer therapies, and palliative care for cancer patients. Through registries that save, display, and analyse data to prioritise and track cancer control efforts, the programme aims to increase cancer survival and encourage cancer epidemiological monitoring.

poland breast cancer therapeutics market

Market Dynamics

Market Growth Drivers

Being the most prevalent cancer in the world, breast cancer will continue to fuel the growth of the Poland breast cancer therapeutics market. As more people are diagnosed with breast cancer worldwide, there is a growing demand for effective and precise therapy for those who have the disease. Future innovative therapies will be attainable as a result of the leading market participants' strong tendency toward ongoing research and development in the field of breast cancer therapeutics. The introduction of cutting-edge treatments like immunotherapies and targeted medicines is anticipated to greatly accelerate the growth of the Polish market.

Market Restraints

The Poland breast cancer therapeutics market for breast cancer medications is being constrained by unfavourable side effects brought on by drug use along with the high cost of treatment of targeted therapies and hormonal therapies in Poland.

Competitive Landscape

Key Players

  • Neuca (POL)
  • Farmacol (POL)
  • Polska Grupa Farmaceutyczna (POL)
  • Polpharma (POL)
  • Bristol-Myers Squibb
  • Eli Lilly
  • Halozyme
  • Merck

Healthcare Policies and Regulatory Landscape

Every Polish citizen resident has the right to affordable healthcare, which is provided by the National Health Fund (NFZ), under the country's free public healthcare system. Every Polish citizen is required to make a payment to the organisation in the form of an 8.5% deduction from their own income. The majority of the money for publicly funded, cost-free health insurance comes from these deductions. The National Health Fund is in charge of organising and funding healthcare in Poland, including the treatment of breast cancer. For women aged 50 to 69, the NFZ has launched a national breast cancer screening programme that includes mammography every two years. Women who have a higher risk of getting breast cancer, like those with a family history of the condition, may be eligible for earlier and more regular screenings. Surgery, radiation therapy, and chemotherapy are all available treatment options for breast cancer in Poland.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Poland Breast Cancer Therapeutics Segmentation

By Therapy (Revenue, USD Billion):

  • Radiation Therapy
    • Targeted Therapy
      • Ribociclib
      • Abemaciclib
      • Afinitor
      • Everolimus
      • Trastuzumab
      • Olaparib
      • Ado-Trastuzumab Emtansine
      • Palbociclib
      • Pertuzumab
      • Herceptin
      • Tykerb (Lapatinib)
      • Others
  • Hormonal Therapy
    • Selective Estrogen Receptor Modulators (SERMs)
    • Aromatase Inhibitors
    • Estrogen Receptor Downregulators (ERDs)
  • Chemotherapy
    • Taxanes
    • Anthracyclines
    • Anti-metabolites
    • Alkylating Agents
  • Immunotherapy

By Cancer Type (Revenue, USD Billion):

  • Hormone Receptor
  • HER+

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 10 January 2024
Updated by: Dhruv Joshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up